Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and Recent Advances in NK Cell-Targeted Immunotherapies in Solid Tumors
Guang‐Yu Lian, Thomas Shiu‐Kwong Mak, Xueqing Yu, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 164-164
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

T cells, NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems
Yalong Yang, Fei Yang, Zhuan-qing Huang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 33
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 19
(Dis)similarities between the Decidual and Tumor Microenvironment
Jelena Krstić, Alexander Deutsch, Julia Fuchs, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1065-1065
Open Access | Times Cited: 25
Disrupting Smad3 potentiates immunostimulatory function of NK cells against lung carcinoma by promoting GM-CSF production
Guang‐Yu Lian, Qingming Wang, Thomas Shiu‐Kwong Mak, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 4
Update on immune‐based therapy strategies targeting cancer stem cells
Amirhossein Izadpanah, Niloufar Mohammadkhani, Mina Masoudnia, et al.
Cancer Medicine (2023) Vol. 12, Iss. 18, pp. 18960-18980
Open Access | Times Cited: 11
WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.
Jiansong Wang, Jianjun Luo, Xuecheng Wu, et al.
PubMed (2024) Vol. 39, Iss. 5, pp. 633-646
Closed Access | Times Cited: 3
Contemporary Approaches to Immunotherapy of Solid Tumors
A. V. Kuznetsova, Ksenia А. Glukhova, О. П. Попова, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2270-2270
Open Access | Times Cited: 3
Impaired intratumoral natural killer cell function in head and neck carcinoma
Dalila Mele, Greta Pessino, Giuseppe Trisolini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 12
Opportunities and challenges of natural killer cell-derived extracellular vesicles
Yuchen Qi, Xiang Zhao, Yan Dong, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 6
Enhancing the Anti-Tumor Efficacy of NK Cells on Canine Mammary Tumors through Resveratrol Activation
Tingting Zhu, Shengzi Jin, Danning Tong, et al.
Animals (2024) Vol. 14, Iss. 11, pp. 1636-1636
Open Access | Times Cited: 1
Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy
Stefania Douka, Vasilis Papamoschou, Monica Raimo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1143-1143
Open Access | Times Cited: 1
The Evolving Applications of Bispecific Antibodies: Reaping the Harvest of Early Sowing and Planting New Seeds
Diego Ellerman
BioDrugs (2024)
Closed Access | Times Cited: 1
Classic and Current Opinions in Human Organ and Tissue Transplantation
Angus Nnamdi Oli, Adekunle Babajide Rowaiye, Samson Adedeji Adejumo, et al.
Cureus (2022)
Open Access | Times Cited: 7
Murine models to study human NK cells in human solid tumors
Monica Parodi, Simonetta Astigiano, Paolo Carrega, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Investigation of the efficacy and feasibility of combined therapy of PD‐L1‐enhanced exogenous peripatetic adoptive natural killer (NK) cells in combination with antiangiogenic targeted therapy in the treatment of extensive‐stage small cell lung cancer
Zhizhen Wang, Ruiping Zhang, Yuchan Cao, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 28, pp. 2877-2885
Open Access | Times Cited: 3
ZL-1211 Exhibits Robust Antitumor Activity by Enhancing ADCC and Activating NK Cell–mediated Inflammation in CLDN18.2-High and -Low Expressing Gastric Cancer Models
Hiroyasu Konno, Tracey Lin, Renyi Wu, et al.
Cancer Research Communications (2022) Vol. 2, Iss. 9, pp. 937-950
Open Access | Times Cited: 5
Cancer Immunotherapy Via Stem Cell-Derived NK Cells
Fatemeh Hosseini, Mohammad Ahmadvand, Roya Karimi, et al.
Immunotherapy (2023) Vol. 15, Iss. 12, pp. 963-973
Closed Access | Times Cited: 2
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies
Yangjie Liu, Peng Cao, Faiza Ahad, et al.
Recent Patents on Anti-Cancer Drug Discovery (2024) Vol. 19, Iss. 5, pp. 557-572
Closed Access
Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model
Yi‐Ping Hung, Chia-Chun Tu, Jiun‐I Lai, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Finding potential targets in cell-based immunotherapy for handling the challenges of acute myeloid leukemia
Amir Hossein Kheirkhah, S Habibi, Mohammad Hasan Yousefi, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Commentary: On the Emerging Role of Innate Lymphoid Cells in Bladder Cancer
Zaineb Hassouneh, Gang Huang, Nu Zhang, et al.
Journal of Cancer Immunology (2024) Vol. 6, Iss. 3, pp. 125-134
Closed Access
Allograft persistence: The next frontier for allogeneic γδ T cell therapy
Daniel Fowler, Jonathan Fisher
Elsevier eBooks (2024), pp. 155-183
Closed Access
Current Developments in NK Cell Engagers for Cancer Immunotherapy: Focus on CD16A and NKp46
Min Hwa Shin, Eunha Oh, Dohsik Minn
Immune Network (2024) Vol. 24, Iss. 5
Open Access
Current landscape of clinical use of ex vivo expanded natural killer cells for cancer therapy
Júlia Teixeira Cottas de Azevedo, Juliana Aparecida Preto de Godoy, Cláudia Souza, et al.
Einstein (São Paulo) (2024) Vol. 22
Open Access
Page 1 - Next Page

Scroll to top